Racemic propranolol has been shown to be an effective antidysrhythmic agent in many circumstances (Frieden, 1967; Gettes and Surawicz, 1967;  Gibson and Sowton, 1969) , including the management of ventricular fibrillation following infarction (Sloman, Robinson, and McLean, 1965) .
Its depressant effects on myocardial function (Bay, Lund-Larsen, Lorentsen, and Sivertssen, 1967) limit its use in seriously ill patients, although Stannard, Sloman, and Sangster (1968) reported that the reduction in cardiac output could be largely prevented by the addition of atropine. The dextro-isomer of propranolol (I.C.I. 47,319) is almost devoid of blocking activity during an isoprenaline challenge in animal investigations (Howe and Shanks, 1966) and in normal volunteers (Shanks, 1968, personal communication) . D-Propranolol possesses considerable antidysr&hythmic activity and will rapidly revert ouabain-induced tachycardia in dogs and cats to sinus rhythm (Howe and Shanks, 1966) . Howitt was able to control various dysrhythmias in 59 patients (Howitt, Husaini, Rowlands, Logan, Shanks, and Evans, 1968) and reported that 5-20 mg. of dextropropranolol given intravenously was as effective as the racemic drug in treating ventricular and supraventricular ectopic beats. In six of his patients the dextro-isomer terminated digitalisinduced dysrhythmias. It seems possible that dextro-propranolol might be indicated in preference to the racemic drug in patients following cardiac infarction. This report concerns the haemodynamic effects of D-propranolol in 13 patients with recent cardiac infarction.
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MATERIAL AND METHODS
All patients were admitted to the coronary care unit of the National Heart Hospital and were being monitored both electrocardiographically and haemodynamically. There were 10 men and three women, with ages ranging from 35 to 65 years. Cardiac infarction was diagnosed with a typical history of pain supported by elevation of serum enzymes (SGOT and/ or LDH) and characteristic ST-T changes in the cardiogram. All patients were studied within 24 hours of the onset of pain.
Aortic and pulmonary artery pressures were recorded via fine catheters introduced percutaneously, and cardiac output was measured by a dye dilution technique using cardiogreen dye and a Gilford cuvette, as in previous reports from this department (Balcon. Hoy, and Sowton, 1968) . The zero level for pressures was the mid chest with the patient supine.
Following control readings 20-25 mg. D-propranolol was injected via the pulmonary artery catheter, and measurements were repeated at intervals of 15 and 30 minutes. Statistical analysis was by Student's 't' test.
RESULTS
There was no significant change in heart rate, systemic pressure, pulmonary artery pressure, peripheral resistance, stroke volume, stroke work, left ventricular work or Tension Time Index (TTI) during the 30 minutes after administration of the drug.
The cardiac output fell in seven patients, the maximal effect occurring at 15 minutes. The mean change for the whole group was 0 8 1./min., and this was not statistically significant (010>P>0 O5). An overall reduction was still present at 30 minutes. In association with the changes in cardiac output, stroke volume and left ventricular work were also reduced, but the changes were not signi-86 (Julian, 1969) . The other criteria of cardiac function showed no significant change either in our own or in other investigations. These results suggest that most of the depression of function produced by the racemic mixture is due to the beta-blockade produced by the laevo isomer. Although both isomers of propranolol have direct depressant action on the myocardium in animals, these are not prominent at dose levels equivalent to those used clinically (Barrett, 1969) .
Dextro-propranolol produces a transient reduction in coronary vascular resistance followed by an increase to above control levels when injected into the coronary arteries of dogs (Whitsitt and Lucchesi, 1967) , and this effect has been attributed to a non-specific action of the drug, unrelated to adrenergic receptor blockade. This effect is shared by DL-propranolol The work for this paper was in part supported by grants from the British Heart Foundation, to whom we are most grateful. It is a pleasure to thank Miss Janet Woods for her invaluable technical assistance. 
